Unicycive Therapeutics
OrganizationHeard in 1 episode across 1 show since Oct 2026
Unicycive Therapeutics, Inc. is a clinical-stage biotechnology company developing novel treatments for kidney diseases. Its lead investigational product, oxylanthanum carbonate, is a phosphate-binding agent being developed for patients with chronic kidney disease.
Episodes
1
across 1 show
First heard
Oct 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
Email alert
Email me when Unicycive Therapeutics comes up on a podcast
One email a week at most, with the new episodes that mention Unicycive Therapeutics. Free, no account needed, unsubscribe in one click.
Episodes
1 episode featuring Unicycive Therapeutics, newest first
